Postgraduate Studentships - Search for funding opportunities.
Postgraduate Studentships - Search for funding opportunities.
Study Details: MSc Study mode and duration: 12 months full-time, 24 months part-time
unique in the UK
Why this course?
The MSc in Cancer Therapies is unique in the UK. It’s a multifaceted course and the only one which combines a focus on cancer biology, drug discovery, formulation and delivery with radiation biology. You’ll also gain an understanding of the practical, ethical and economic implications of personalised cancer therapy. The degree is for graduates seeking experience in the range of topics essential to the understanding and development of cancer therapies.
You’ll be taught in the Strathclyde Institute of Pharmacy & Biomedical Sciences, recognised as one of the leading departments of its kind in the UK. The Institute has major facilities for radiobiology and radiopharmaceutical research. It also hosts the Cancer Research UK Drug Formulation Unit – the only one of its kind in the UK. You’ll therefore be taught by researchers working at the forefront of basic, translational, industrial and clinical cancer research in the biomedical and physical sciences arenas.
The course has been developed to produce world-class graduates with the skills to contribute to the global drive in advancing cancer treatment through research, teaching, industry and public sector employment.
Minimum second-class Honours degree, or international equivalent in a science or health-related subject
For fees and funding options, please visit website to find out more
The University of Strathclyde was the first university to win the coveted Times Higher Education University of the Year title twice! The University o...
